Penn I-Corps Program Promotes Interdisciplinary Entrepreneurship Amongst Faculty and Students
Through our training in customer discovery, participants learn how to identify a niche market for their innovations, guiding them from idea to impact.
Technology to help Newborns in the NICU wins 2023 President’s Innovation Prize
Penn President Liz Magill awarded the 2023 President’s Innovation Prize toGabriella Daltoso, Sophie Ishiwari, Gabriela Cano, Caroline Amanda Magro, and Tifara Eliana Boyce for their project, Sonura.
Penn I-Corps Launches Spring 2023 cohort
The cohort started at the end of February and is underway. Teams are currently engaged in reaching out and conducting Customer discovery interviews.
Three Penn Spinouts Made Philadelphia Business Journal’s PHLInno List of Top Philadelphia Startups to Watch in 2023
Exciting news for three innovative Penn spinouts.
Penn I-Corps Fall 2022 Cohort
In Fall 2022, ten teams participated in the Penn I-Corps Program, representing the Schools of Arts and Sciences, Engineering, Medicine, Veterinary Medicine, and Business.
Vetigenics Founder Nicola Mason Featured on CBS 60 Minutes for Canine Cancer Research
Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.
Penn spinout and I-Corps participant NeuroFlow raises $25 million growth round, doubles headcount and expands into Center City office
The funding will help Neuroflow, a Philadelphia-based mental health startup, make greater investments in research and development, expand its technology platform and increase headcount.
Penn Spinout and I-Corps Participant Innervace Raises $40 Million for Parkinson’s Disease Research
The funds will allow Innervace to advance their platform and lead asset in Parkinson’s disease, which aims to reconstruct the neuronal circuitry that is lost in Parkinson's patients.
Penn ICorps Graduate and President’s Innovation Prize Winner Strella Biotech Raises $8 Million in Series A Funding Round
Read about how this Philadelphia-based agricultural biotech startup received funding from Mark Cuban, Google Ventures, and others.